Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | $3.17M | -$1.11M | -25.9% | Mar 1, 2025 |
EOLS | Evolus, Inc. | Director | $418K | -$167K | -28.6% | Mar 12, 2025 |
ANEB | Anebulo Pharmaceuticals, Inc. | Director | Apr 21, 2022 | |||
ARCT | Arcturus Therapeutics Holdings Inc. | Director | Jun 18, 2021 | |||
TNYA | Tenaya Therapeutics, Inc. | Director | Oct 18, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|